Clinical trial · Interventional
Tele-Navigation of Lung Cancer Screening (Tele-Navi LCS)
Tele-Navigation of Lung Cancer Screening
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Adherence to annual follow up is critical to achieving mortality benefits and optimizing cost-effectiveness of lung cancer screening (LCS). However, adherence to LCS follow-up in the real world is suboptimal. Using telehealth, the investigators will co-create Tele-Navigation of Lung Cancer Screening with patients and LCS stakeholders as an intervention to promote adherence of follow-up LCS. The investigators will then implement the Tele-Navi LCS intervention to a pilot sample of patients and evaluate its feasibility in the primary care setting. The investigators will measure the number of patient participants who completed Tele-Navi LCS and follow-up LCS within 180 days from Tele-Navi LCS.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Lung Cancer | Malignant Lung Neoplasm | CURATED_EXACT | 0.92 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Tele-Navi LCS | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Tele-Navi LCS
- description
- Tele-Navi of LCS includes: telehealth coaching from a Tele-Navigator for patients undergoing LCS
- interventionNames
- Behavioral: Tele-Navi LCS
Primary outcomes (1)
- measure
- Completion of Tele-Navi LCS
- timeFrame
- 30 days
- description
- Number of participants completed Tele-Navi LCS,
Secondary outcomes (1)
- measure
- Completion of Follow-up LCS
- timeFrame
- 180 days
- description
- Number of participants who received a low-dose CT (LDCT) for LCS follow-up
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 50 Years
- Maximum age
- 77 Years
Show eligibility criteria text
Inclusion Criteria: * Is eligible for LDCT for LCS follow-up * Has technology to complete study activities (e.g., video call visit) * English speaker * Has undergone LCS at UMMH * Is overdue for LDCT follow-up Exclusion Criteria: * Has previous diagnosis of lung cancer * Has active cancer diagnosis * Is a nursing home or group care resident * Is pregnant
References
Publications (0)
Data not yet available